ΔNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells

• Published in: Journal of neuro-oncology Vol. 72; no. 1; pp. 29 - 34
• Main Authors: SIMOES-WÜST, A. P, SIGRIST, B, BELYANSKAYA, L, DONALDSON, S. Hopkins, STAHEL, R. A, ZANGEMEISTER-WITTKE, U
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer 01.03.2005
• Subjects: Biological and medical sciences; Development. Senescence. Regeneration. Transplantation; Fundamental and applied biological sciences. Psychology; Isolated neuron and nerve. Neuroglia; Medical sciences; Neurology; Vertebrates: nervous system and sense organs; Nervous system diseases; ΔNp73; bax; Malignant tumor; Neuroblastoma; Autonomic neuropathy; PUMA; Apoptosis; antisense
• ISSN: 0167-594X; 1573-7373
• DOI: 10.1007/s11060-004-3118-8

The p73 gene codes for various different protein isoforms. They include proteins expressed under the control of the P1 promoter that contain a transactivation domain and are similar in function to p53 (TAp73 isoforms), as well as proteins regulated by the P2 promoter that lack this domain and function as dominant negative inhibitors of TAp73 and p53 ( Delta Np73 isoforms). Whereas TAp73 functions as a tumor suppressor with pro-apoptotic function, Delta Np73 is likely to prevent the induction of apoptosis in tumor cells and to participate in oncogenesis. Here we used a loss-of-function strategy to assess the role of Delta Np73 in SH-SY5Y neuroblastoma cells. An antisense oligonucleotide designed to target Delta Np73 mRNA, but not TAp73, was used to effectively downregulate this transcript. Delta Np73 downregulation was accompanied by increased levels of the pro-apoptotic BH3 family member PUMA at the mRNA and protein level, and by conformational activation of BAX which translocated to mitochondria. These Delta Np73 antisense-mediated alterations led to the induction of apoptosis as detected by decreased cell viability, augmented DNA fragmentation and increased caspase-3 activity in cell lysates. Our results demonstrate the cytoprotective role of Delta Np73 in neuroblastoma and suggest its use as a target for molecular intervention therapy.